Cargando…

Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma

This study is to identify significant dosimetric parameters for ear disorders in nasopharyngeal carcinoma (NPC) patients treated with intensity modulated therapy only. Ninety-seven patients with NPC were retrospectively reviewed. Organs at risk (OARs) in the auditory apparatus were contoured. Dose–v...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Ji-Jin, Zhou, Guan-Qun, Lin, Li, Zhang, Wang-Jian, Peng, Ying-Lin, Chen, Lei, Tang, Ling-Long, Mao, Yan-Ping, Ma, Jun, Sun, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642560/
https://www.ncbi.nlm.nih.gov/pubmed/26323586
http://dx.doi.org/10.1038/srep13525
_version_ 1782400379533656064
author Yao, Ji-Jin
Zhou, Guan-Qun
Lin, Li
Zhang, Wang-Jian
Peng, Ying-Lin
Chen, Lei
Tang, Ling-Long
Mao, Yan-Ping
Ma, Jun
Sun, Ying
author_facet Yao, Ji-Jin
Zhou, Guan-Qun
Lin, Li
Zhang, Wang-Jian
Peng, Ying-Lin
Chen, Lei
Tang, Ling-Long
Mao, Yan-Ping
Ma, Jun
Sun, Ying
author_sort Yao, Ji-Jin
collection PubMed
description This study is to identify significant dosimetric parameters for ear disorders in nasopharyngeal carcinoma (NPC) patients treated with intensity modulated therapy only. Ninety-seven patients with NPC were retrospectively reviewed. Organs at risk (OARs) in the auditory apparatus were contoured. Dose–volume histogram parameters were generated for the Eustachian tube (ET), tympanic cavity (TC), mastoid air cells, vestibular apparatus, cochlea and internal auditory canal (IAC). Ear disorders were rated 0 (none), 1 (mild) or 2 (severe) by a clinician blinded to radiation doses; Grade 2 ear disorders was the study end-point. Multivariate analysis revealed ET.D(30) (dose to 30% of ET volume) >52.75 Gy and M.D(0.5CC) (dose to 0.5 ml of mastoid volume) >41.04 Gy (OR = 3.77, P = 0.012 and OR = 1.27, P = 0.033, respectively) were associated with Grade 2 ear disorders. Our results demonstrated that post-irradiation ear disorders remain a common late toxicity in NPC after IMRT. ET.D(30) and M.D(0.5CC) should be considered during IMRT treatment plan optimization, review and approval.
format Online
Article
Text
id pubmed-4642560
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46425602015-11-20 Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma Yao, Ji-Jin Zhou, Guan-Qun Lin, Li Zhang, Wang-Jian Peng, Ying-Lin Chen, Lei Tang, Ling-Long Mao, Yan-Ping Ma, Jun Sun, Ying Sci Rep Article This study is to identify significant dosimetric parameters for ear disorders in nasopharyngeal carcinoma (NPC) patients treated with intensity modulated therapy only. Ninety-seven patients with NPC were retrospectively reviewed. Organs at risk (OARs) in the auditory apparatus were contoured. Dose–volume histogram parameters were generated for the Eustachian tube (ET), tympanic cavity (TC), mastoid air cells, vestibular apparatus, cochlea and internal auditory canal (IAC). Ear disorders were rated 0 (none), 1 (mild) or 2 (severe) by a clinician blinded to radiation doses; Grade 2 ear disorders was the study end-point. Multivariate analysis revealed ET.D(30) (dose to 30% of ET volume) >52.75 Gy and M.D(0.5CC) (dose to 0.5 ml of mastoid volume) >41.04 Gy (OR = 3.77, P = 0.012 and OR = 1.27, P = 0.033, respectively) were associated with Grade 2 ear disorders. Our results demonstrated that post-irradiation ear disorders remain a common late toxicity in NPC after IMRT. ET.D(30) and M.D(0.5CC) should be considered during IMRT treatment plan optimization, review and approval. Nature Publishing Group 2015-09-01 /pmc/articles/PMC4642560/ /pubmed/26323586 http://dx.doi.org/10.1038/srep13525 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Yao, Ji-Jin
Zhou, Guan-Qun
Lin, Li
Zhang, Wang-Jian
Peng, Ying-Lin
Chen, Lei
Tang, Ling-Long
Mao, Yan-Ping
Ma, Jun
Sun, Ying
Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
title Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
title_full Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
title_fullStr Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
title_full_unstemmed Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
title_short Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
title_sort dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642560/
https://www.ncbi.nlm.nih.gov/pubmed/26323586
http://dx.doi.org/10.1038/srep13525
work_keys_str_mv AT yaojijin dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT zhouguanqun dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT linli dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT zhangwangjian dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT pengyinglin dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT chenlei dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT tanglinglong dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT maoyanping dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT majun dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma
AT sunying dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma